Nuvectis Pharma, Inc.
NASDAQ:NVCT
8.35 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -19 | -22.26 | -19.085 | -12.89 | -0.024 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 4.858 | 4.705 | 1.707 | 1.892 | 0 |
| Change In Working Capital
| 1.895 | 1.74 | 3.819 | 1.494 | 0.01 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.273 | -0.139 | 4.14 | 1.585 | 0 |
| Other Working Capital
| 2.168 | 1.879 | -0.321 | -0.091 | 0.01 |
| Other Non Cash Items
| 0 | -0.139 | -2.433 | 0.307 | 0.024 |
| Operating Cash Flow
| -12.247 | -15.954 | -13.559 | -9.504 | 0.024 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 12.036 | 5.289 | 31.879 | 15.246 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.382 | 9.798 | -4.069 | 15.246 | 0 |
| Financing Cash Flow
| 11.654 | 15.087 | 27.81 | 15.246 | 0 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -0.593 | -0.867 | 14.251 | 5.742 | 0.024 |
| Cash At End Of Period
| 18.533 | 19.126 | 19.993 | 5.742 | 0.024 |